期刊文献+

miR-544a对非小细胞肺癌细胞系Wnt信号通路抑制因子GSK3β表达的调控作用 被引量:4

Expression of GSK3β,an inhibitory factor of the Wnt signaling pathway,in non-small cell lung cancer regulated by miR-544a
下载PDF
导出
摘要 目的探讨微小RNA-544a(miR-544a)对肺癌干细胞的自我更新能力影响及其可能的机制。方法通过生物信息学预测miR-544a的靶向基因,用荧光素酶报告系统及western blot验证其靶向关系;构建稳定表达miR-544a的非小细胞肺癌(NSCLC)细胞系95C和95D,并用荧光定量PCR验证;用肿瘤球悬浮培养实验检测miR-544a在形成肿瘤球中的作用。结果生物信息学预测发现,miR-544a可以靶向调节Wnt信号通路的抑制子GSK3β,并通过荧光素酶报告系统得到了验证(F=201.37,P<0.01);western blot结果显示,miR-544a可以下调GSK3β的表达,而β-catenin、CD133蛋白表达水平明显上调(F分别为7.73,3.37,9.43,P均<0.01);荧光定量PCR结果显示,95C、95D细胞在转染miR-544a后,miR-544a表达水平增高,分别为20.51±0.97、15.16±1.38(F=418.05,P<0.01)。肿瘤球悬浮培养实验发现,稳定表达miR-544a的细胞能够反复形成具有肿瘤干细胞特性的肿瘤球。结论 miR-544a可以通过直接下调GSK3β的表达来激活Wnt信号通路,以维持肺癌干细胞自我更新能力。 Objective To investigate the effect and its mechanism of miR-544a on the self-renewal ability of lung cancer stem cells. Methods The target genes of miR-544a were predicted by bioinformatics, and were verified with the luciferase reporter system and western blot. In the meanwhile, the non-small cell lung cancer (NSCLC) cell lines expressing miR-544a stably, 95C and 95D, were constructed, and validated by qPCR. The tumor spheroid culture was used to assess the effect of miR-544a on the formation of lung cancer stem cells. Results Bioinformatics analysis indicated that miR-54da could regulate the expression of GSK3β, an inhibitory factor of Wnt signaling pathway, which was verified by the luciferase reporter system ( F = 201.37, P 〈 0.01 ). western blot revealed that miR-544a could inhibit the expression of GSK3i3, while increase the levels of β-catenin and CD133 proteins in 95C and 95D cells ( F = 7.73, 3.37 and 9.43, respectively, P 〈 0.01 ). qPCR showed that the expressions of miR-544a increased to 20.51 ± 0.97 and 15.16 ± 1.38 (P 〈0.01 ), respectively, after miR-544a was transfected into 95C or 95D cells. The tumor spheroid culture revealed that the cells expressing miR-544a stably could form the spheroids with the features of tumor stem cells repeatedly. Conclusion miR- 544a was able to activate the Wnt signaling pathway by reducing the expression of GSK3β, and subsequently maintain the self-renewal ability of lung caner stem ceils.
出处 《临床检验杂志》 CAS CSCD 北大核心 2013年第10期761-764,共4页 Chinese Journal of Clinical Laboratory Science
关键词 miR-544a 非小细胞肺癌 肿瘤干细胞 GSK3Β WNT信号通路 miR-544a non-small cell lung cancer tumor stem cell GSK3β Wnt signaling pathway
  • 相关文献

参考文献12

  • 1Lobo NA, Shimono Y, Qian D, et aL The biology of cancer stemcells [ J]. Annu Rev Cell Dev Biol, 2007 , 23 : 675-699.
  • 2DeanM,Fojo T, Bates S. Tumor stem cells and drug resistance[ J].Nat Rev Cancer, 2005, 5(4) =275-284.
  • 3LinCT, Lyu YL, Xiao H, et al. Suppression of gene amplificationand chromosomal DNA integration by the DNA mismatch repair sys-tem [J]. Nucleic Acids Res,2001,29( 16) ;3304-3310.
  • 4StaalFJ, Luis TC, Tiemessen MM. WNT signalling in the immunesystem : WNT is spreading its wings [ J]. Nat Rev Immunol, 2008,8(8):581-593.
  • 5Malanehi I,Peinado H, Kassen D,et al. Cutaneous cancer stem cellmaintenance is dependent on beta-catenin signaling [ J]. Nature,2008,452(7187) =650-653.
  • 6王亚南,史进方,吴元健,徐卫东,蒋敏,顾国浩.microRNA在非小细胞肺癌组织中的表达及其临床应用研究[J].临床检验杂志,2011,29(7):516-519. 被引量:16
  • 7Ma R, Zhang G, Wang H, et al. Downregulation of miR-544 in tis-sue ,but not in serum, is a novel biomarker of malignant transforma-tion in glioma[ J]. Oncol Lett,2012,4(6) : 1321-1324.
  • 8SunL, Wu Z, Shao Y, et al. MicroRNA-34a suppresses cell prolif-emtion and induces apoptosis in U87 glioma stem cells [ J]. TechnolCancer Res Treat, 2012, 11(5) :483-490.
  • 9Li Q, Yao Y, Eades G,et al. Downregulation of miK-140 promotescancer stem cell formation in b^ai-like early stage breast cancer[J]. Oncogene, 2013. doi : 10.1038/onc. 2013.226.
  • 10FanX, Chen X, Deng W, et al. Up-regulated microRNA-143 incancer stem cells differentiation promotes prostate cancer cells me-tastasis by modulating FNDC3B expression [ J]. BMC Cancer,2013, 13:61.

二级参考文献10

  • 1Liu X, Sempere LF, Ouyang H, et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by re- pressing specific tumor suppressors [ J]. J Clin Invest, 2010, 120 (4) :1298-1309.
  • 2Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation [ J ]. Cancer Res, 2005,65 (21) :9628-9632.
  • 3Seike M, Goto A, Okano T, eta(. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers [ J ]. Proc Natl Acad Sci USA, 2009,106 ( 29 ) : 12085 -12090.
  • 4Garofalo M, Di Leva G, Romano G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 down-regulation[ J]. Cancer Cell, 2009,16 (6) :498-509.
  • 5Liu B, Peng XC, Zheng XL, et al. MiR-126 restoration downregu- late VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo[J]. Lung Cancer, 2009,66(2) :169-175.
  • 6Shi B, Sepp-LorenzinoL, PriscoM, et al. MicroRNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells[J]. J Biol Chem, 2007,282(45 ) :32582-32590.
  • 7Livak K J, Sehmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△Ct method[ J]. Meth- ods, 2001,25(4) :402-408.
  • 8Garofalo M, Quintaballe C, Di Leva G, et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer[J]. Onco- gene, 2008,27 ( 27 ) : 3845-3855.
  • 9Crawford M, Brawner E, Batte K, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines [ J ]. Biochem Biophy Res Commun, 2008,373 (4) :607-612.
  • 10辇伟奇,陈芳琳,敖绪军,陈正堂.miR-223在CXCR4^+ Lewis肺癌细胞中的显著低表达及其靶基因预测[J].第三军医大学学报,2009,31(22):2202-2205. 被引量:2

共引文献15

同被引文献31

  • 1Tang X, Zheng D, Hu P, et al. Glycogen synthase kinase 3 beta in- hibits microRNA-183-96-182 cluster via the --catenin/TCF/l,EF-Ipathway in gastric cancer cells [ J ]. Nucleic Acids Res, 2013, [ Epub ahead of print J.
  • 2Gavilrn E, Srnchez-Aguayo I, Daza P, et al. GSK-313 signaling deter- mines autophagy activation in the breast tumor cell line MCF7 and inclu- sion formation in the non-tumor cell line MCF10A in response to protea- some inhibition[J]. Cell Death & Disease, 2013, 4(4) : e572.
  • 3Jamieson CH, Ailles LE, Dylla S J, et al. Granuloeyte-macrophage progenitors as candidate leukemic stem ceils in blast-crisis CML [ J]. N Engl J Med, 2004, 351(7) : 657-667.
  • 4Abrahamsson AE, Geron I, Gotlib J, et al. Glyeogen synthase ki- nase 3beta missplieing contributes to leukemia stem cell generation [J]. Proc Natl Acad Sci USA, 2009, 106(10) :3925-3929.
  • 5Wang ET, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue transcriptomes [ J ]. Nature, 2008, 456 (7221) : 470-476.
  • 6David C J, Chen M, Assanah M, et al. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer [ J ]. Nature, 2010,463(7279) : 364-368.
  • 7Brosseau JP, Lucier JF, Nwilati H, et al. Tumor microenvironment- associated modifications of alternative splicing [ J ]. RNA, 2014,20 (2) :189-201.
  • 8Pal S, Gupta R, Davulufi RV. Alternative transcription and altemative splicing in cancer[ J 3. Pharmacol Ther, 2012,136(3) :283-294.
  • 9Bonomi S, Gallo S, Catino M, et al. Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy [ J ]. Int J Cell Biol, 2013,2013:962038.
  • 10Vargas IM, Vivas-Mejla PE. Assessment of mRNA splice variants by qRT-PCR[J]. Methods Mol Biol, 2013,1049:171-186.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部